25 April 2024 - NICE is unable to make a recommendation on the use of melphalan flufenamide hydrochloride (Pepaxti) in combination ...
24 April 2024 - A new targeted drug combination treatment, described as a ‘step-change in care’ for children and young ...
24 April 2024 - NICE is unable to make a recommendation on the use of pembrolizumab (Keytruda) in combination with cisplatin ...
23 April 2024 - PHARMAC is proposing to fund more treatments for people with a type of blood cancer, multiple ...
11 April 2024 - Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia. ...
10 April 2024 - Amelia Ramsay has battled all her life – and now she may have to watch her kids ...
10 April 2024 - NICE has published final evidence-based recommendations on the use of cabozantinib maleate (Cabometyx) in combination with ...
3 April 2024 - NICE has published final evidence-based recommendations on the use of dostarlimab (Jemperli) in combination with platinum-based ...
2 April 2024 - Roche designed its trial for both approval and health technology assessments but the analyses planned for ...
2 April 2024 - Breast cancer experts have urged PHARMAC to fast-track the drug Keytruda, for Kiwis with an aggressive ...
27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one ...
26 March 2024 - We describe temporal trends in expenditure on cancer medicines within the single-payer health system of Ontario, Canada, ...
28 February 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
6 March 2024 - NICE has published final evidence-based recommendations on the use of epcoritamab (Tepkinly) for the treatment of ...
6 March 2024 - NICE has published final draft guidance that does not recommend Enhertu (trastuzumab deruxtecan; Daiichi Sankyo) for treating ...